Su et al. have confirmed that targeting PD-1 in the T cells from patient with melanoma and gastric cancer resulted in the improvement of cytotoxicity of T cells, and the tumor cells were killed (Su et al., 2016). The gene discussed is PDCD1; the disease is melanoma.